טוען...

Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis

The use of immunobiological agents for the treatment of autoimmune diseases is increasing in medical practice. Anti-TNF therapies have been increasingly used in refractory autoimmune diseases, especially rheumatoid arthritis, with promising results. However, the use of such therapies has been associ...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Dias, Olívia Meira, Pereira, Daniel Antunes Silva, Baldi, Bruno Guedes, Costa, André Nathan, Athanazio, Rodrigo Abensur, Kairalla, Ronaldo Adib, Carvalho, Carlos Roberto Ribeiro
פורמט: Artigo
שפה:Inglês
יצא לאור: Sociedade Brasileira de Pneumologia e Tisiologia 2014
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4075924/
https://ncbi.nlm.nih.gov/pubmed/24626274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1806-37132014000100012
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!